Gastroenterology clinical treatment and nursing of patients with chronic atrophic gastritis
慢性萎缩性胃炎患者的消化内科临床治疗与护理

摘要

目的 对消化内科慢性萎缩性胃炎患者治疗手段及临床价值进行研究，以期能够为消化内科护理人员开展工作提供一些参考。方法 本次实验时间为2019年1月-2020年1月，实验对象为本院消化内科慢性萎缩性胃炎患者，实验人数共计110人，医护人员在实验过程中依据治疗手段的不同将患者分为甲乙两组，两组患者人数相同，均为55人。医护人员应采取阿莫西林、克拉霉素及枸橼酸泌钾等药物对甲组患者进行治疗，采取替普瑞酮及甲组患者所用药物对乙组患者进行治疗，记录和分析两组患者治疗时长、治疗总有效率及不良反应出现情况。结果 研究结果显示，在治疗时长方面，乙组患者要远远短于甲组患者，甲组患者治疗时长为（13.7±1.1）天，乙组患者治疗时长为（5.8±0.6）天，治疗时长方面表现出较大差异，数据呈现统计学意义（p＜0.05）；在治疗总有效率方面，与甲组患者相比，乙组患者较高，甲乙两组患者治疗总有效率分别为69.09%及96.36%，治疗总有效率方面表现出显著差异，数据呈现统计学意义（p＜0.05）；在不良反应出现方面，相比甲组患者，乙组患者并发症出现几率较低，甲组共有3例患者出现不良反应，不良反应出现几率为5.45%，乙组共有1例患者出现不良反应，不良反应出现几率为1.82%，不良反应出现几率方面表现出明显差异，数据呈现统计学意义（p＜0.05）。结论 在消化内科慢性萎缩性胃炎患者治疗中，同时应用替普瑞酮及常规药物的效果要远远优于单一使用阿莫西林、克拉霉素及枸橼酸泌钾等药物，联合用药能够在一定程度上缩短治疗时长，优化治疗效果，减少不良反应的出现，具有较高的临床应用价值。

Abstract

Objective: To study the treatment methods and clinical value of patients with chronic atrophic gastritis in the Department of Gastroenterology, so as to provide some reference for the nursing staff of the Department of Gastroenterology.
Methods: The experiment was conducted from January 2019 to January 2020. The subjects of the experiment were patients with chronic atrophic gastritis in the Department of Gastroenterology of the hospital. The total number of the experiment was 110. Medical staff divided the patients according to different treatment methods during the experiment. The two groups are A and B, and the number of patients in the two groups is the same, both being 55. Medical staff should take amoxicillin, clarithromycin and potassium citrate and other drugs to treat group A patients, take teprenone and the drugs of group A patients to treat group B patients, record and analyze the two groups of patients’ treatment duration, total treatment efficiency and occurrence of adverse reactions.
Results: The results of the study showed that in terms of treatment duration, the patients in group B were much shorter than those in group A. The treatment duration for group A patients was (13.7 ± 1.1) days, and the treatment duration for group B patients was (5.8 ± 0.6) days. There was a big difference in duration, and the data showed statistical significance (p <0.05); in terms of the total treatment efficiency, compared with the patients in group A, the patients in group B were higher, and the total effective rates of patients in groups A and B were 69.09 % and 96.36%, the total effective rate of treatment showed a significant difference, the data showed statistical significance (p <0.05); in terms of adverse reactions, compared with group A patients, group B patients had a lower probability of complications, witha total of 3 patients in group A had adverse reactions, and the odds of occurrence of adverse reactions were 5.45%. A total of 1 patient in Group B had adverse reactions. The odds of occurrence of adverse reactions were 1.82%. There was a significant difference in the probability of adverse reactions. The data showed statistical significance ( p <0.05).
Conclusion  : In the treatment of patients with chronic atrophic gastritis in the gastroenterology department, the effect of simultaneous application of teprenone and conventional drugs is far better than that of amoxicillin, clarithromycin, potassium citrate and other drugs. To a certain extent, shortening the treatment time, optimizing the treatment effect, and reducing the occurrence of adverse reactions have high clinical application value.